CIC BiomaGUNE
Centro (uo)
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (7)
2024
-
High-throughput virtual search of small molecules for controlling the mechanical stability of human CD4
Journal of Biological Chemistry, Vol. 300, Núm. 4
2020
-
Structure-Guided Design of a Group B Streptococcus Type III Synthetic Glycan–Conjugate Vaccine
Chemistry - A European Journal, Vol. 26, Núm. 31, pp. 7018-7025
-
Structure-Guided Design of a Group B Streptococcus Type III Synthetic Glycan-Conjugate Vaccine
Chemistry (Weinheim an der Bergstrasse, Germany), Vol. 26, Núm. 31, pp. 6944
2009
-
Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PET
NeuroImage, Vol. 46, Núm. 2, pp. 447-458
2006
-
Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1 - Pseudoequilibrium interval and quantification methods
Journal of Nuclear Medicine, Vol. 47, Núm. 6, pp. 919-928
-
Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 2 - Ketanserin displacement
Journal of Nuclear Medicine, Vol. 47, Núm. 6, pp. 929-937
1994
-
A Bioactive Fullerene Peptide
Journal of Medicinal Chemistry, Vol. 37, Núm. 26, pp. 4558-4562